Laparoscopic versus open gastrectomy for gastric cancer patients with COPD

Background Patients with chronic obstructive pulmonary disease (COPD) have a higher risk of developing postoperative pulmonary complications. Laparoscopic gastrectomy (LG) is accepted as a standard treatment for early gastric cancer. We sought to compare the clinical presentation and complications a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2009-11, Vol.100 (6), p.456-458
Main Authors: Chang, Hao-Ming, Lee, Sang-Woong, Nomura, Eiji, Tanigawa, Nobuhiko
Format: Article
Language:English
Subjects:
Aged
Blood Loss, Surgical
Carbon Dioxide - blood
Cohort Studies
COPD
Female
Gastrectomy - methods
gastric cancer
Humans
laparoscopic gastrectomy
Laparoscopy
Length of Stay
Male
Postoperative Complications
pulmonary complications
Pulmonary Disease, Chronic Obstructive - classification
Pulmonary Disease, Chronic Obstructive - complications
Retrospective Studies
Stomach Neoplasms - complications
Stomach Neoplasms - surgery
Tidal Volume
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Patients with chronic obstructive pulmonary disease (COPD) have a higher risk of developing postoperative pulmonary complications. Laparoscopic gastrectomy (LG) is accepted as a standard treatment for early gastric cancer. We sought to compare the clinical presentation and complications associated with LG and open gastrectomy (OG) to define the role of LG in the treatment of patients with gastric cancer and COPD. Methods This was a retrospective cohort study of patients with gastric cancer and COPD who underwent gastrectomy from January 2005 to December 2007. Patients were divided into LG group and OG group according to the treatment guidelines. The stage of COPD was determined by the FEV1 ratio. Results There were 104 patients enrolled in this study. No significant differences were observed in preoperative pulmonary function between the two groups, and most patients (99/104, 95%) were in COPD stages I and II. The changes in end‐tidal CO2 (P = 0.012) and PaCO2 (P 
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.21339